The next #ESMOGuidelines webinar focuses on #GastroesophagealCancer — from biomarker testing to immunotherapy integration.
🎙 Live Q&A with expert faculty
🎓 Earn 1 ESMO-MORA Cat. 1 point
🆓 Open to all with an ESMO account
🔗 Join us: https://ow.ly/SU2g50YlJnP
#ESMOOnAir #ESMOWebinars
📣Updated ESMO #ClinicalPracticeGuideline on advanced and metastatic #ProstateCancer:
✅ Substantial advances in castration-sensitive & -resistant prostate cancer
✅ Updated algorithms & recommendations reflecting latest clinical data
#ESMOGuidelines Christopher Sweeney
🔗 https://ow.ly/E4ov50Yc8e2
📣ESMO #ClinicalPracticeGuideline Express Update on #EpithelialOvarianCancer:
- Rucaparib: 1st-line PARPi maintenance option
- MIRV: for recurrent FRα-high #OvarianCancer after 1-3 prior therapies & PFI <6 months
🔗 https://ow.ly/J06u50Y4HT8
#GYNOnc #Oncology #ESMOGuidelines
📣 ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: 💡CHALLENGE trial suggests survival benefits from structured exercise
👥Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines
🔗 https://ow.ly/lJY850Y49fR
👉 Join us for the #ESMOGuidelines webinar to get practical insights on ctDNA, NGS, MSI‑H/dMMR and targeted treatments to support personalised #CRC care.
Open to all ESMO account holders.
🔗Register here: https://ow.ly/kE7S50Y1Ljw
#ESMOWebinar #ESMOOnAir #CancerGuidelines
📣 Updated ESMO #ClinicalPracticeGuideline on local & locoregional #ProstateCancer:
✅New imaging modalities: Improved diagnosis, staging & risk stratification
✅Updated algorithms: less over-Tx & fewer side-effects
#Oncology #UroOncology #CancerCare #ESMOGuidelines
🔗 https://ow.ly/jwA650XLs1q
👉 Innovation is reshaping #prostatecancer care! Explore new therapies, imaging & evidence-based strategies in the #ESMOGuidelines webinar
🔗 Free with your ESMO account: https://ow.ly/RN1E50XAug9
#ESMOWebinars #ESMOOnAir
👉 Join the upcoming #ESMOGuidelines Webinar to explore #realworldcases, expert insights & the latest treatment strategies in #lymphoma
🔗 Free with your ESMO account: https://ow.ly/xaKa50XuGaW
📖 ESMO Clinical Practice Guidelines at #ESMO25 #ESMOGuidelines
Session I: HCC & melanoma
📅 19 Oct | 10:15–11:45 | Hall 7.1c
Session II: Lymphomas & early-stage NSCLC
📅 19 Oct | 14:45–16:15 | Hall 7.1c
🔗 buff.ly/h4FL2cU
📣 New ESMO #Lymphomas Living Guideline v1.0.
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.
🔗 https://ow.ly/wLFE50X7y9e
#ESMOGuidelines
👉 Join the upcoming #ESMOGuidelines Webinar to explore #realworldcases, expert insights & the latest treatment strategies in #melanoma
🔗 Free with your ESMO account: buff.ly/Q783hIx
📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes.
🔗 buff.ly/Yn640wo
#LungCancer #SystemicTherapy #Oncology #CancerTreatment #ESMOGuidelines
📣Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines
🔗 buff.ly/fvvPb26
📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx.
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines
🔗 buff.ly/2ZYJc2c
📣 ESMO Living Guidelines on Metastatic Colorectal Cancer v1.3: Updated recommendations and algorithms for the treatment of patient with BRAF-mut.
🔗 buff.ly/hlp0K4S
#ESMOGuidelines
👉 ESMO Living Guidelines on Localised Rectal Cancer: New title in the library with all recommendations and algorithms from the published Guideline in an interactive format.
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance.
#LungCancer #mNSCLC #ESMOGuidelines
🔗 buff.ly/DSLyGib
📣Updated ESMO #ClinicalPracticeGuideline recommendations in the non-oncogene-addicted metastatic #NSCLC: new 1L Tx options approved.
🔗 buff.ly/da21Bml
#LungCancer #mNSCLC #ESMOGuidelines
ESMO Guidelines: Real World Cases - Webinar Series: Metastatic Breast Cancer 2025
@myesmo.bsky.social
oncodaily.com/blog/esmo-gu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOGuidelines #BreastCancer #mBC
👉 Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes.
Join this live discussion and submit your questions
🔗 buff.ly/nj2nMtC
📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: situation-dependent intensification & de-intensification, complex radiological factors, #biomarkers & selective Tx goals via organ-preserving strategies form options & decisions
#ESMOGuidelines
🔗 buff.ly/GPnKSMY
📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up.
🔗 buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines
🆕Brand new online! #EHA & #ESMO collaborated to bring you this #ClinicalPracticeGuideline on #PTCL. We warmly invite you to read & share with your contacts 👉 bit.ly/PTCL_GL
@myesmo.bsky.social #EHAGuidelines #ESMOGuidelines
👉Join us for the #ESMOGuidelines webinar on #rectalcancer! Don't miss out on expert insights and practical case discussions.
Register now:
🔗 buff.ly/XUlyWOO
📣ESMO #ClinicalPracticeGuideline Express Update on #PancreaticCancer: updated 1st- & #2nd-line treatment recommendations for managing #MetastaticPancreaticCancer, following approval of 1st-line nanoliposomal #irinotecan. #ESMOGuidelines
🔗https://buff.ly/Mybc2Nq
@ducreuxmichel.bsky.social
Proposed treatment algorithm for the management of patients with stage III/IV melanoma according to prior adjuvant treatment received - Amaral et al. Ann Oncol 2024
🔥 Hot off the press!
The most updated #ESMOguidelines on cutaneous melanoma, now out in #AnnOncol. Great to see #TheChristie colleagues @beckilee.bsky.social & Paul Lorigan as co-authors in this panel of esteemed experts 🌍.
🔗 Available #OpenAccess: www.annalsofoncology.org/article/S092...
